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ABSTRACT
Objective: The objective of this study is to evaluate the reversal effects of aqueous and ethanolic extracts of jamun seeds against high-fructose (HFr) 
diet-induced insulin resistance (IR) in albino rats.
Methods: Thirty male albino rats were divided into five groups (n=6), and all the group rats except normal control were provided with HFr (60% w/v) 
to their drinking water daily for 42 days. Group 1 and 2 served as a normal and fructose control. Groups 3, 4, and 5 were supplemented with metformin 
(MET 500mg/kg p.o) and aqueous and ethanolic extracts of jamun seeds (Jamun seed aqueous extract [JSAE] and Jamun seed ethanolic extract [JSEE] 
1000 mg/kg of each p.o), from day 28 to day 42, respectively. Physical (body weights, food, and water intake) and biochemical (glucose, insulin, and 
lipid) parameters were estimated, and Homeostasis model assessment (HOMA)-IR values were calculated.
Results: HFr diet significantly (p<0.05) increased weight gain and water intake with decreased food intake in rats. HFr-fed rats exhibited a 
significant (p<0.05) increase in fasting glucose, insulin, and lipid levels along with increased HOMA-IR values and confirms the development of IR. 
Supplementation with MET, JSAE, and JSEE significantly (p<0.05) restored the physical parameters and reversed fasting glucose and lipid levels in 
comparison with HFr control. Whereas, only JSAE had significantly reversed the fasting insulin levels in comparison with HFr control. HOMA-IR values 
were significantly (p<0.05) decreased in both the extract groups of HFr-fed rats, and the results were comparable to MET.
Conclusion: Our study concludes that both aqueous and ethanolic extracts of jamun exhibit a significant reversal effect against HFr diet-induced IR, 
due to insulin-sensitizing actions at the target tissues.
Keywords: Eugenia jambolana, Fructose, Insulin resistance, Hyperglycemia, Hyperlipidemia and Metformin.
INTRODUCTION
Diabetes mellitus is a metabolic disorder characterized by chronic 
hyperglycemia either due to a deficiency of insulin secretion or a 
decrease in insulin sensitivity and/or both [1]. Type 2 diabetes often 
characterized by peripheral insulin resistance (IR) and insufficient 
functional mass of ß-cells [1,2]. Persistent hyperglycemia is often 
associated with long-term complications and had shown a significant 
impact on the quality of life and as well as on the health-care system [3]. 
According to the World Health Organization (WHO), the prevalence of 
type 2 diabetes will increase by up to 300 million by 2025 and could be 
due to lifestyle changes, consumption of calorie-rich diets, and obesity. 
India will be a diabetic capital of the world and sharing the global 
burden by 2025 [4-7].
IR develops due to the decrease in insulin action, insulin-stimulated 
glucose uptake, and dispose of the target tissues, often observed with 
hyperglycemia, hyperinsulinemia, and hyperlipidemia. IR is a central 
pathophysiological feature of type 2 diabetes and associated with 
dyslipidemia, obesity, hypertension, and atherosclerosis [8]. However, 
glucose intolerance in IR could be either due to the loss of insulin 
action or pancreas to induce hyperinsulinemia. IR owes to deregulate 
carbohydrate and lipid metabolism which are responsible for the 
oxidative stress that may lead to morbidity and mortality [9].
Fructose consumption has been dramatically increasing in the developed 
and industrialized nations. It is a lipogenic nutrient and commonly used 
as a sweetener in both food and pharmaceutical industries. Fructose is 
rapidly absorbed from the intestine and transported to the liver through 
the portal vein. Unlike glucose, fructose uptake and metabolism are not 
regulated by negative-feedback mechanisms in the liver [10,11]. Hence, 
long-term high-fructose (HFr) diet intake causes deleterious effects 
on body weight, glucose, and lipid metabolism, resulting in increased 
synthesis of fatty acids (FAs) and triglycerides (TGs) which impair 
insulin sensitivity and which lead to IR [12]. Feeding of rats with HFr 
diet (>60% of total calories) results in several metabolic abnormalities 
due to the modification of insulin action and signaling pathways. 
Therefore, the HFr diet is used as an animal model to induce either 
type-2 diabetes associated with IR or metabolic syndrome (MetS) [5].
Glitazones and biguanides are insulin-sensitizing agents which are 
commonly used in the treatment of IR. However, the use of glitazones 
was associated with several adverse effects such as weight gain, 
bladder cancer, fractures, and hepatotoxicity [2]. The WHO Expert 
Committee on Diabetes (1980) had recommended the use of traditional 
plants to reverse and/or prevent metabolic disorders. They are widely 
being used because of their effectiveness, less or no side effects, and 
relatively economical. In response to the pertaining problem, attempts 
were made to identify the plants that are having insulin-sensitizing 
as well as antihyperlipidemic effects. Therefore, need of a scientific 
evaluation of their efficacy in IR animal models may become extremely 
useful [12,13].
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Eugenia jambolana (Family: Myrtaceae) is commonly known as jamun 
and widely distributed in India and the Asian countries. E. jambolana 
has shown various pharmacological activities which include 
antidiarrheal [14], gastric antisecretory [15], antioxidant [16], 
anti-inflammatory [17], antibacterial [18], anti-HIV [19], and 
neuropsychopharmacological [20] effects. Pre-clinical and clinical 
studies have shown that E. jambolana seed has antidiabetic and 
antihyperlipidemic activities [21-23]. According to a review of the 
literature, there is a lack of scientific work on insulin-sensitizing 
effects of jamun seed extracts on HFr diet-induced IR model. Hence, 
the present study was intended to investigate the reversal effects 
of jamun seed extracts on hyperinsulinemia, hyperglycemia, and 
hyperlipidemia in HFr diet-induced IR in rats.
METHODS
Experimental animals
Male Wistar Albino rats, initially weighing 240–300 g, were obtained 
from the animal house and maintained at 22±3°C, humidity of 55±5%, 
and 12 h/12 h light-dark cycle with free access to food and water ad 
libitum. The experimental protocol (Ref.No: KSHEMA/IAEC/16/2015) 
was approved by the Institutional Animal Ethics Committee and 
followed the CPCSEA guidelines. Animal experimentation was carried 
only after 1 week of acclimation period. The study had been conducted 
in the Department of Pharmacology, K.S. Hegde Medical Academy 
(KSHEMA), Mangalore.
Drugs and chemicals
Fructose was procured from LOBA Chemie, Pvt., Ltd, Bengaluru. 
Metformin (MET) was supplied in the form of Glycomet Tablets, 
USV Ltd., Mumbai, and ketamine injection was obtained from Neon 
Laboratories Ltd., Mumbai, India. Both the glucose and lipid profile kits 
were purchased from Agappe Diagnostics, Kerala. Serum insulin kit was 
obtained from RayBio, Delhi. All the other chemicals and reagents used 
for the experimental purpose were of analytical grade.
Plant extracts
Both the aqueous and ethanolic extracts of E. jambolana (batch.no JFE/
D26/STD03 and STD04) were obtained from GreenChem, Bengaluru.
Experimental design
Male albino rats were randomly divided into five groups of six rats in 
each and provided with a standard pellet diet daily. All the rats except 
normal control received HFr diet (60% w/v) added to their drinking 
water for 42 days. Group 1 served as a normal control received gum 
acacia (2%, p.o) and Group 2 served as HFr control received HFr 
(60% w/v) for 42 days. Groups 3, 4, and 5 received HFr supplementation 
with Metformin (MET 500 mg/kg) and aqueous and ethanolic extracts 
of the jamun seed (JSAE and JSEE 1000 mg/kg of each), respectively, 
orally from day 28 to day 42 (Table 1). Blood samples were collected 
on days 1 and 42 under ketamine anesthesia from the overnight, fasted 
rats and centrifuged at 3,000 RPM for 10 min to carry out biochemical 
estimations.
Biochemical estimations
Blood glucose, total cholesterol (TC), TG, and high-density lipoprotein 
(HDL) levels (mg/dl) using the kit methods through Semi-Auto 
analyzer (Star 21 plus), respectively. Serum insulin (µIU/ml) was 
measured by Enzyme-Linked Immunosorbent Assay (ELISA) method, 
using an ELISA reader (Rapid Diagnostics Pvt., Ltd.). The biochemical 
analysis had been carried out in the Central Research Laboratory, 
KSHEMA, Mangalore.
Low-density lipoprotein cholesterol (LDL) was calculated according to 
the Friedewald’s equation and very low-density lipoprotein cholesterol 
(VLDL) with TG/5 equation [24].
Homeostasis model assessment (HOMA)-IR was calculated by using the 
following equation [25]:
HOMA-IR=Fasting insulin (µIU/ml)×Fasting glucose (mg/dl)/405
Determination of physical parameters
Body weights
Weekly changes in their body weight of all group rats were recorded, 
and the weight gain of each rat was calculated by subtracting day 1 from 
the day 42 body weight.
Food and water intake
Daily food intake was calculated by deducting the amount of food left 
in the cage from the amount of food provided to each group, and the 
weekly average of daily food intake was calculated. Similarly, an average 
of daily water intake was also recorded.
Statistical analysis
Values are expressed as mean±standard error of the mean. One-way 
ANOVA followed by Tukey’s multiple comparison tests, to assess the 
statistical significance with GraphPad prism. p<0.05 was considered as 
statistically significant.
RESULTS
Effect on body weight
At the end of the study, all groups exhibited a significant (p<0.05) 
increase in their body weight and weight gain in comparison to 
normal control. Body weight and weight gain in HFr control were 
significantly (p<0.05) increased from a normal control. Administration 
of MET significantly (p<0.05) reversed the increased body weight 
and weight gain as compared to HFr control. However, on HFr dietary 
supplementation with JSAE and JSEE for 14 days, failed to reverse 
increased body weight as compared to HFr control. There is no 
significant difference (p>0.05) in a weight gain of JSAE but exists with 
JSEE as compared to MET (Figs. 1 and 2).
Effect on food and water intake
Long-term feeding of HFr diet significantly (p<0.05) reduced food 
intake and increased water intake, in comparison to normal control. 
The MET significantly reversed (p<0.05) the reduced food intake and 
increased water intake in comparison to HFr control. Supplementation 
of HFr diet with JSAE and JSEE also reversed the reduced food intake 
and increased water intake in comparison to HFr control. Both jamun 
extracts did not exhibit a significant (p>0.05) difference in food and 
water intake, except JSAE with MET (Figs 3 and 4).
Effect on fasting glucose and insulin
No significant (p>0.05) difference was observed in the initial fasting 
glucose and insulin levels in all groups. Fasting glucose and insulin 
Table 1: Experimental grouping
Groups.no Groups (n=6) Drugs and dosage
Group 1 Normal control Water (2% gum acacia, p.o)
Group 2 HFr control HFr (60% w/v+2% gum acacia, p.o)
Group 3 MET HFr+MET (500 mg/kg+2% gum acacia, p.o)
Group 4 JSAE HFr+JSAE (1000 mg/kg+2% gum acacia, p.o)
Group 5 JSEE HFr+JSEE (1000 mg/kg+2% gum acacia, p.o)
MET: Metformin, HFr: High-fructose, JSAE: Jamun seed aqueous extract, JSEE: Jamun seed ethanolic extract
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levels were significantly (p<0.05) elevated in HFr control as compared 
to normal control, indicating the establishment of hyperglycemia 
and hyperinsulinemia of IR in rats. However, administration of MET 
significantly (p<0.05) reversed the fasting glucose and insulin levels 
as compared to HFr control, and the results were comparable to 
normal control, concerned with the glucose levels. It was observed 
that increased fasting glucose levels were significantly (p<0.05) 
reversed by feeding HFr supplementation with JSAE and JSEE, as 
compared to HFr control, and also exhibit significant (p<0.05) 
differences with normal control and MET group. JSAE has reduced 
fasting insulin levels as compared to HFr control, and both the 
extracts exhibit significant differences (p<0.05) with normal control 
and MET group (Table 2).
Effect on IR index
HFr control rats exhibited a significant (p<0.05) increase in HOMA-
IR values as compared to normal control, due to hyperglycemia and 
hyperinsulinemia at the end of the experiment. MET significantly 
(p<0.05) reversed increased HOMA-IR values as compared to HFr 
control and exhibited comparable effects with normal control.Both 
the jamun extract groups, significantly (P<0.05) reversed the elevated 
HOMA-IR values as compared to HFr control group (Table 2).
Effect on lipid profile
HFr feeding significantly (p<0.05) increased TC, TG, VLDL, and LDL with 
decreased HDL levels in comparison to normal control and signifies the 
rise of hyperlipidemia associated with IR in rats. Administration of MET 
significantly (p<0.05) decreased TC, TG, VLDL, and LDL with a significant 
(p<0.05) increase in HDL levels as compared to HFr control and also 
significantly (p<0.05) varies with normal control. HFr supplementation 
with JSAE and JSEE significantly (p<0.05) decreased TC, TG, VLDL, and 
LDL levels in comparison with HFr control and significantly (p<0.05) 
differed with normal control. However, JSAE but not JSEE significantly 
(p<0.05) restores the HDL levels and varies with normal control. Both 
extract groups exhibit comparable effects with the MET in reversing 
lipid abnormalities in HFr-fed rats (Tables 3 and 4).
DISCUSSION
IR is observed before the onset of diabetes and often aggravated by several 
factors such as genetic, lifestyle, obesity, other diseases, and drugs such 
as glucocorticoids and protease inhibitors [1]. Fructose intake increases 
the risk of diabetes, obesity, and non-alcoholic fatty liver disease [12]. 
Fig. 1: Effect of aqueous and ethanolic extracts of E. jambolana 
seeds on body weights in high-fructose (HFr) diet-induced insulin 
resistance rats. Data are expressed as mean±standard error 
of the mean. a, b, and c mean significantly (p<0.05) different 
as compared with normal control, HFr control, and metformin 
groups, respectively, on the day 42
Fig. 2: Effect of aqueous and ethanolic extracts of E. jambolana 
seeds on weight gain in high-fructose (HFr) diet-induced insulin 
resistance rats. Data are expressed as mean±standard error 
of the mean. a, b, and c mean significantly (p<0.05) different 
as compared with normal control, HFr control, and metformin 
groups, respectively, on the day 42
Fig. 3: Effect of aqueous and ethanolic extracts of E. jambolana 
seeds on average food intake in high-fructose (HFr) diet-induced 
insulin resistance rats. Data are expressed as mean±standard 
error of the mean. a, b, and c mean significantly (p<0.05) different 
as compared with normal control, HFr control, and metformin 
groups, respectively, on the day 42
Fig. 4: Effect of aqueous and ethanolic extracts of E. jambolana 
seeds on average water intake in high-fructose (HFr) diet-induced 
insulin resistance rats. Data are expressed as mean±standard 
error of the mean. a, b, and c mean significantly (p<0.05) different 
as compared with normal control, HFr control, and metformin 
groups, respectively, on the day 42
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Our study finding was supported by Mielke et al., who had stated that 
the HFr diet produces hippocampal IR. HFr diet (60%w/v) was most 
commonly used to induce hypertriglyceridemia, hyperinsulinemia, and 
hyperglycemia in hamsters, as reported by de Moura et al. and Suga et 
al. Among the various diabetic animal models, HFr diet mimics many 
symptoms of diabetes. Hence, this model has been used for the screening 
of effective and safer insulin sensitizers against IR [26-29].
In the present study, male rats were employed because female rats fail to 
develop IR with the HFr diet, probably due to the protective effects of the sex 
hormones in them [9,30]. Consumption of HFr diet significantly decreased 
food intake and increased calorie intake, (through fructose drinking water) 
promoted fat deposition, and weight gain in rats over a period. Excess 
calorie intake may be because of HFr that can alter leptin levels, play a 
significant role in regulating food intake and energy expenditure, thereby 
increase calorie intake, and encourage weight gain [31]. Both the MET and 
extracts restored water intake, due to decreased hyperglycemia and blood 
osmolarity which diminished stimulating effects on the hypothalamus 
and decreased polydipsia as observed in IR. Supplementation with JSAE 
extract effectively reduced weight gain in HFr-fed rats by decreasing FA 
oxidation, and thereby reducing lipid storage in the tissues. Similarly, both 
the extracts have improved food intake by ameliorating insulin-sensitizing 
action and glucose abnormalities.
Hyperglycemia in HFr-fed rats was due to excess hepatic gluconeogenesis 
as a consequence of IR. Fructose increases the hexosamine pathway for 
glucose production, plays a crucial role in the development of IR and 
hyperlipidemia in rats. It does not stimulate insulin secretion directly, 
but the subsequent hyperglycemia with increased release of glucose-
dependent insulin tropic polypeptide and glucose like peptide-I from the 
intestine enhances insulin secretion contributes to hyperinsulinemia [6]. 
Fructose stimulates the β-cells to enhance insulin secretion and decreases 
insulin extraction by the liver with a delay in insulin clearance from 
circulation, leading to hyperinsulinemia [32]. The fasting glucose and 
insulin levels reflect HOMA-IR values and hence used to quantify the 
IR. A decrease in HOMA-IR values indicates the improvement of IS by 
reversing glucose and/or insulin concentration in HFr-fed rats[29,33]. In 
our study, HFr supplementation with MET and jamun extracts significantly 
reversed HOMA-IR values and exhibits antihyperglycemic effect through 
their insulin-sensitizing action rather than an increased insulin secretion.
In the liver, fructose increases the rate of de novo lipogenesis and TG synthesis. 
Hence, both TGs and free fatty acids (FFA) enhance the glycogenolysis, 
successively increase the hepatic glucose levels, and later lead to extrahepatic 
IR [2,4]. Before phosphofructokinase metabolizes fructose, it gets converted 
into glycerol and FFAs, which are taken up by the adipose tissue, leading to 
additional adiposity. The lipogenic nature of fructose increases the synthesis 
and release of atherogenic lipoproteins. Fructose-induced hyperglycemia 
also promotes lipid peroxidation and increases oxidative stress, which 
impairs insulin action at the cellular level. Hypertriglyceridemia and 
hypercholesterolemia are the most important factors to increase the risk 
of coronary heart disease [34]. Either increased HDL or decreased oxidized 
LDL levels will improve endothelial dysfunction by enhancing nitric oxide 
production and offers protection against atherosclerosis, most commonly 
seen in IR with obesity [9,27]. Hence, the present investigation demonstrates 
that both MET and Jamun extracts exhibited antihyperlipidemic effects 
by decreasing TC, TG, and LDL with an increase in HDL levels except JSEE 
group. Therefore, jamun extracts can be used to reverse hyperlipidemia in IR 
patients, according to ATP III guidelines.
Table 2: Effect of aqueous and ethanolic extracts of E. jambolana seeds on fasting glucose, insulin, and HOMA-IR in HFr diet-induced IR 
rats
Groups Fasting glucose (mg/dl) Fasting insulin (µIU/L) HOMA-IR
Day 1 Day 42 Day 1 Day 42 Day 1 Day 42
Group 1 98.88±4.52 113.92±4.88 25.60±3.38 28.23±3.4 6.41±1.11 8.08±1.19
Group 2 103.47±3.68 216.51±9.36a 33.15±3.78 123.19±7.38 a 8.62±1.24 66.65±6.6a
Group 3 87.02±6.21 126.21±5.43b 24.35±3.51 65.26±5.26a, b 5.48±1.12 20.61±2.46b
Group 4 100.32±4.79 162.19±6.06a, b, c 34.78±5.09 94.13±6.32a, b, c 8.9±1.66 38.16±3.96a, b, c
Group 5 95.80±4.53 170.29±7.14a, b, c 30.73±4.87 106.19±4.56a, c 7.5±1.44 45.02±3.74a, b, c
Data are expressed as mean±SEM. a, b, and c mean significantly (p<0.05) different as compared with mormal control, HFr control, and MET groups respectively on 
the day 42. E. jambolana: Eugenia jambolana, HOMA-IR: Homeostasis model assessment-insulin resistance, HFr: High fructose, SEM: Standard error of the mean, 
MET: Metformin
Table 3: Effect of aqueous and ethanolic extracts of E. jambolana seeds on fasting lipid profile (TC, TGs, and HDL) in HFr diet-induced IR 
rats
Groups TC TGs HDL
Day 1 Day 42 Day 1 Day 42 Day 1 Day 42
Group 1 73.35±2.78 78.2±2.97 50.7±4.66 55.93±2.77 48.07±2.49 53.7±2.69
Group 2 71.82±2.5 179.15±9.65a 60.97±4.33 221.42±7.94a 45.52±3.72 19.78±3.36a
Group 3 74.92±3.72 125.51±6.2a, b 56.68±4.35 132.37±4.24a, b 47.6±2.54 34.91±3.1a, b
Group 4 77.09±4.55 134.88±5.73a, b 51.98±3.29 147.84±7.07a, b 49.52±4.09 36.57±4.2a, b
Group 5 69.48±4.08 146.5±6.17a, b 50.14±4.12 160.02±6.87a, b, c 44.74±3.55 31.85±2.47a
Data are expressed as Mean±SEM. a, b, and c mean significantly (p<0.05) different as compared with normal control, HFr control, and MET groups, respectively, 
on the day 42. E. jambolana: Eugenia jambolana, HFr: High fructose, IR: Insulin resistance, TC: Total cholesterol, TG’s: Triglycerides, HDL: High-density lipoprotein, 
SEM: Standard error of the mean, MET: Metformin
Table 4: Effect of aqueous and ethanolic extracts of E. jambolana 
seeds on fasting lipid profile (VLDL and LDL) in HFr 
diet-induced IR rats
Groups VLDL LDL
Day 1 Day 42 Day 1 Day 42
Group 1 10.14±0.93 11.19±0.55 15.13±1.68 13.31±1.18
Group 2 12.19±0.87 44.28±1.59a 14.11±1.6 115.09±8.1a
Group 3 11.34±0.87 26.47±0.85a, b 15.98±0.93 64.12±5.96a, b
Group 4 10.4±0.66 29.57±1.41a, b 17.18±1.61 68.75±6.92a, b
Group 5 10.03±0.82 32±1.37a, b, c 14.71±1.06 82.64±3.18a, b
Data are expressed as Mean±SEM. a, b, and c mean significantly (p<0.05) 
different as compared with normal control, HFr control, and MET groups, 
respectively, on the day 42. E. jambolana: Eugenia jambolana, HFr: High fructose, 
IR: Insulin resistance, VLDL: Very low-density lipoprotein-cholesterol, 
LDL: Low-density lipoprotein-cholesterol, SEM: Standard error of the mean, 
MET: Metformin
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CONCLUSION
The promising results have shown that both jamun extracts can mitigate 
the hyperglycemia, hyperlipidemia, and hyperinsulinemia by improving 
insulin action at the target tissues, with a decrease in HOMA-IR index in 
HFr-fed rats. Hence, the study concludes that the reversal effects of jamun 
extracts were similar to insulin-sensitizing actions of MET and advised as 
a food supplement in IR patients associated with metabolic abnormalities.
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